Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of CSL Influenza Vaccine in Children
NCT00825162Phase 4Completed
- Sponsor
- CSL Seqirus
- Start
- Mar 2009
- Primary completion
- Feb 2010
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of standard dose influenza vaccine in influenza, sponsored by CSL Seqirus. Started Mar 2009; status: completed.
02
Drugs
standard dose influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00825162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00825162.